IMU Biosciences
London
About IMU Biosciences
IMU is a discovery engine mapping the immune system to advance precision medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2024)
- Website: imubiosciences.com
Industries & Categories
Biotechnology, Health Care, Life Science, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/imu-biosciences-105976 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.